The Connecticut Board of Physicians is considering adding anxiety and four other conditions to the state’s medical marijuana program.
The board is holding a public hearing Wednesday at 8:30 a.m. on whether to add anxiety, migraines, hydrocephalus, Menieres disease and trigeminal neuralgia to the list of disorders treatable using medical marijuana in the state.
Following the public hearing, the board will make recommendations to the state Department of Consumer Protection (DCP), which then goes through another public process in the legislature before being approved.
In January, the Board of Physicians proposed adding fibromyalgia, rheumatoid arthritis, and post herpetic neuralgia, which also includes peripheral neuropathy and Allodynia from shingles. Those are under legislative review, said Consumer Protection Commissioner Michelle H. Seagull.
There are 18,198 medical marijuana patients in the program, with 22 conditions approved for adults, and six conditions approved for youth.
The hearing will be held at the DCP offices at 450 Columbus Blvd., in Hartford in North Meeting Rooms C and D.
